Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Contriving multiepitope subunit vaccine by exploiting structural and nonstructural viral proteins to prevent Epstein–Barr virus‐associated malignancy

26 Oct 2018

Abstract excerpt

Cancer is one of the common lifestyle diseases and is considered to be the leading cause of death worldwide. Epstein-Barr virus (EBV)-infected individuals remain asymptomatic; but under certain stress conditions, EBV may lead to the development of cancers such as Burkitt's and Hodgkin's lymphoma and nasopharyngeal carcinoma. EBV-associated cancers result in a large number of deaths in Asian and African...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lymphoma Diagnosis and Treatment
Share to vaccines and immunoinformatics approaches
Share to Viral-associated cancers and disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30362500
DOI: 10.1002/jcp.27380

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Contriving multiepitope subunit vaccine by exploiting structural and nonstructural viral proteins to prevent Epstein–Barr virus‐associated malignancyPMID 30362500Read ↗

Progress in Prophylactic and Therapeutic EBV Vaccine Development Based on Molecular Characteristics of EBV Target AntigensSemantic proximity Read ↗

Designing and immunomolecular analysis of a new broad-spectrum multiepitope vaccine against divergent human papillomavirus typesSemantic proximity Read ↗

An in silico reverse vaccinology approach to design a novel multiepitope peptide vaccine for non-small cell lung cancersSemantic proximity Read ↗

A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infectionSemantic proximity Read ↗

Design of a multi-epitope vaccine against cervical cancer using immunoinformatics approachesSemantic proximity Read ↗

Immunoinformatic and systems biology approaches to predict and validate peptide vaccines against Epstein–Barr virus (EBV)Semantic proximity Read ↗

Designing a T cell multi-epitope vaccine against hRSV with reverse vaccinology: an immunoinformatics approachSemantic proximity Read ↗

Targeting HIV-1 conserved regions: An immunoinformatic pathway to vaccine innovation for the AsiaSemantic proximity Read ↗

A novel vaccine candidate based on chimeric virus-like particle displaying multiple conserved epitope peptides induced neutralizing antibodies against EBV infectionSemantic proximity Read ↗

Next-gen vaccine design: Integrating proteomics and bioinformatics for japanese encephalitisSemantic proximity Read ↗

Integrated Immuno and bioinformatics assisted novel epitope vaccine against HIV infection: a study based on complete genomeSemantic proximity Read ↗

Designing a smallpox B-cell and T-cell multi-epitope subunit vaccine using a comprehensive immunoinformatics approachSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.